share_log

Fractyl Health to Present at BofA Securities 2024 Health Care Conference

Fractyl Health to Present at BofA Securities 2024 Health Care Conference

Fractyl Health 將出席美銀證券 2024 年醫療保健會議
GlobeNewswire ·  05/08 18:00

BURLINGTON, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the "Company"), a metabolic therapeutics company focused on pioneering new approaches for the treatment of obesity and type 2 diabetes (T2D), today announced that Dr. Harith Rajagopalan, CEO of Fractyl Health, will participate in a fireside chat at the upcoming BofA Securities 2024 Health Care Conference on Wednesday, May 15, 2024, at 4:20 p.m. PDT (7:20 p.m. EDT).

馬薩諸塞州伯靈頓,2024年5月8日(GLOBE NEWSWIRE)——專注於開創肥胖和2型糖尿病(T2D)治療新方法的代謝療法公司Fractyl Health, Inc.(納斯達克股票代碼:GUTS)(“公司”)今天宣佈,Fractyl Health首席執行官哈里斯·拉賈戈帕蘭博士將參加即將舉行的美銀證券2024年健康大會的爐邊談話護理會議將於太平洋夏令時間 2024 年 5 月 15 日星期三下午 4:20(美國東部時間晚上 7:20)舉行。

To register in advance for the fireside chat webcast, sign up here.

要提前註冊爐邊聊天網絡直播,請在此處註冊。

A webcast replay will be accessible following the live session on the Events page of the Investors section on the Company's website at

在公司網站 “投資者” 欄目的 “活動” 頁面上直播結束後,將可以觀看網絡直播重播

About Fractyl Health

關於 Fractyl 健康

Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including obesity and T2D. Despite advances in treatment over the last 50 years, obesity and T2D continue to be rapidly growing drivers of morbidity and mortality in the 21st century. Fractyl Health's goal is to transform metabolic disease treatment from chronic symptomatic management to durable disease-modifying therapies that target the organ-level root causes of disease. Fractyl Health is based in Burlington, MA. For more information, visit or .

Fractyl Health是一家代謝治療公司,專注於開創治療包括肥胖和T2D在內的代謝性疾病的新方法。儘管在過去的50年中治療取得了進展,但肥胖和T2D仍然是21世紀發病率和死亡率的快速增長驅動因素。Fractyl Health 的目標是將代謝性疾病治療從慢性症狀管理轉變爲針對器官層面疾病根本原因的持久疾病改善療法。Fractyl Health 總部位於馬薩諸塞州伯靈頓。欲了解更多信息,請訪問或。

Contacts

聯繫人

Corporate Contact
Lisa Davidson, Chief Financial Officer
ir@fractyl.com, 781.902.8800

企業聯繫人
麗莎·戴維森,首席財務官
ir@fractyl.com,781.902.8800

Media Contact
Beth Brett, Corporate Communications
bbrett@fractyl.com, 720.656.6544

媒體聯繫人
Beth Brett,企業傳播
bbrett@fractyl.com,720.656.6544

Investor Contact
Stephen Jasper Gilmartin Group
stephen@gilmartinir.com, 619.949.3681

投資者聯繫人
斯蒂芬·賈斯珀·吉爾馬丁集團
stephen@gilmartinir.com,619.949.3681


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論